Researchers have developed an experimental approach that could open new possibilities for treating glioblastoma, one of the most aggressive forms of brain cancer in adults. The technique combines focused ultrasound, specialised nanoparticles and tiny genetic molecules to target multiple cancer-related genes at the same time.
The research was conducted by scientists , offers a potential new direction for tackling a major challenge in brain cancer treatment: delivering medicines across the brain’s natural protective barrier.
How the New Treatment Works
The experimental technique uses genetic molecules called microRNAs, which can interfere with several genes involved in cancer growth.
To deliver these molecules into the brain, researchers combine nanoparticles with focused ultrasound and microscopic bubbles called microbubbles.
The ultrasound is directed towards a specific area using MRI guidance. This temporarily opens the blood-brain barrier, allowing the nanoparticles carrying microRNAs to enter the targeted region.
Promising Results in Laboratory and Animal Studies
Researchers tested the approach in laboratory experiments and animal models of glioblastoma.
The findings showed that the treatment slowed tumour growth and helped the animals survive longer. It also demonstrated the potential to target several cancer-driving mechanisms simultaneously.
This is particularly important because glioblastoma cells can spread into surrounding healthy brain tissue, making complete surgical removal extremely difficult.
Why Glioblastoma Is Difficult to Treat
Glioblastoma is among the most aggressive malignant brain tumours in adults. One major treatment challenge is the blood-brain barrier, which protects the brain but also prevents many medicines from reaching cancer cells.
Current treatment generally involves surgery to remove as much of the tumour as possible, followed by radiation therapy and chemotherapy.
Despite these treatments, managing the disease remains difficult, creating a need for new approaches.
Human Trials Will Be Needed
Although the initial findings are encouraging, the new technique remains experimental. It has not yet been established as a treatment for patients.
Researchers say further investigation will be necessary before clinical trials can determine whether the approach is safe and effective in humans.
If future studies confirm its potential, focused ultrasound and microRNA technology could become an important area of research for glioblastoma and other difficult-to-treat diseases.
